Nanjing University of Chinese Medicine, 282 HanZhong Road, Nanjing, Jiangsu, 210046, China.
School of Life Sciences, Nanjing University, 163 XianLin Road, Nanjing, Jiangsu, 210093, China.
Sci Rep. 2018 Sep 27;8(1):14477. doi: 10.1038/s41598-018-32734-2.
Colorectal cancer (CRC) is among the most frequently occurring cancers worldwide. Baicalin is isolated from the roots of Scutellaria baicalensis and is its dominant flavonoid. Anticancer activity of baicalin has been evaluated in different types of cancers, especially in CRC. However, the molecular mechanisms underlying the contribution of baicalin to the treatment of CRC are still unknown. Here, we confirmed that baicalin can effectively induce and enhance apoptosis in HT-29 cells in a dose-dependent manner and suppress tumour growth in xenografted nude mice. We further performed a miRNA microarray analysis of baicalin-treated and untreated HT-29 cells. The results showed that a large number of oncomiRs, including miR-10a, miR-23a, miR-30c, miR-31, miR-151a and miR-205, were significantly suppressed in baicalin-treated HT-29 cells. Furthermore, our in vitro and in vivo studies showed that baicalin suppressed oncomiRs by reducing the expression of c-Myc. Taken together, our study shows a novel mechanism for anti-cancer action of baicalin, that it induces apoptosis in colon cancer cells and suppresses tumour growth by reducing the expression of c-Myc and oncomiRs.
结直肠癌(CRC)是全球最常见的癌症之一。黄芩苷从黄芩的根部分离出来,是其主要的黄酮类化合物。黄芩苷已在不同类型的癌症中进行了抗癌活性评估,特别是在 CRC 中。然而,黄芩苷治疗 CRC 的分子机制尚不清楚。在这里,我们证实黄芩苷可以有效诱导和增强 HT-29 细胞的凋亡,并抑制异种移植裸鼠的肿瘤生长。我们进一步对黄芩苷处理和未处理的 HT-29 细胞进行了 miRNA 微阵列分析。结果表明,大量致癌 miRNA,包括 miR-10a、miR-23a、miR-30c、miR-31、miR-151a 和 miR-205,在黄芩苷处理的 HT-29 细胞中显著受到抑制。此外,我们的体外和体内研究表明,黄芩苷通过降低 c-Myc 的表达来抑制致癌 miRNA。综上所述,我们的研究表明了黄芩苷抗癌作用的新机制,即通过降低 c-Myc 和致癌 miRNA 的表达来诱导结肠癌细胞凋亡和抑制肿瘤生长。